45TiP A randomized, molecular driven phase II trial of carboplatin-paclitaxel-bev vs carboplatin-paclitaxel-bev-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced ovarian cancer
Titel:
45TiP A randomized, molecular driven phase II trial of carboplatin-paclitaxel-bev vs carboplatin-paclitaxel-bev-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced ovarian cancer
Auteur:
Scambia, G. Salutari, V. Musacchio, L. Siena, S. Pignata, S. Zavallone, L. Valabrega, G. Cormio, G. Mosconi, A.M. Ricci, C. Ghizzoni, V. Carbone, M.V. Giudice, E. Camarda, F. Nero, C. Tronconi, F. Lorusso, D.